Monitoring of peanut-allergic patients with peanut-specific IgE.

  title={Monitoring of peanut-allergic patients with peanut-specific IgE.},
  author={Rozita Borici-Mazi and Jorge A. Mazza and David William Moote and Keith B Payton},
  journal={Allergy and asthma proceedings},
  volume={29 3},
Peanut allergy affects approximately 1% of the population. Double-blind placebo-controlled food challenges are gold standard for diagnosis. Serum peanut-specific IgE (PN-IgE) is used in clinical practice as an additional diagnostic and monitoring tool. The purpose of this study was to characterize the clinical features of a peanut-allergic patient's cohort… CONTINUE READING